Lyra Therapeuticsinc Stock Price Prediction
| LYRA Stock | USD 4.03 0.60 12.96% |
Oversold Vs Overbought
42
Oversold | Overbought |
Lyra TherapeuticsInc stock price prediction is an act of determining the future value of Lyra TherapeuticsInc shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Lyra TherapeuticsInc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lyra TherapeuticsInc and does not consider all of the tangible or intangible factors available from Lyra TherapeuticsInc's fundamental data. We analyze noise-free headlines and recent hype associated with Lyra TherapeuticsInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Lyra TherapeuticsInc's stock price prediction:EPS Estimate Next Quarter (0.28) | EPS Estimate Current Year (1.29) | EPS Estimate Next Year (1.20) | Wall Street Target Price 11.75 | EPS Estimate Current Quarter (0.31) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Lyra TherapeuticsInc based on different types of headlines from major news networks to social media. The Lyra stock price prediction module provides an analysis of price elasticity to changes in media outlook on Lyra TherapeuticsInc over a specific investment horizon. Using Lyra TherapeuticsInc hype-based prediction, you can estimate the value of Lyra TherapeuticsInc from the perspective of Lyra TherapeuticsInc response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lyra TherapeuticsInc using Lyra TherapeuticsInc's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Lyra using crowd psychology based on the activity and movement of Lyra TherapeuticsInc's stock price.
Lyra TherapeuticsInc Implied Volatility | 325.72 |
Lyra TherapeuticsInc's implied volatility exposes the market's sentiment of Lyra TherapeuticsInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lyra TherapeuticsInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lyra TherapeuticsInc stock will not fluctuate a lot when Lyra TherapeuticsInc's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Lyra TherapeuticsInc. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Lyra TherapeuticsInc to buy its stock at a price that has no basis in reality. In that case, they are not buying Lyra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lyra TherapeuticsInc after-hype prediction price | USD 4.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lyra |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lyra TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lyra TherapeuticsInc After-Hype Price Prediction Density Analysis
As far as predicting the price of Lyra TherapeuticsInc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lyra TherapeuticsInc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lyra TherapeuticsInc, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lyra TherapeuticsInc Estimiated After-Hype Price Volatility
In the context of predicting Lyra TherapeuticsInc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lyra TherapeuticsInc's historical news coverage. Lyra TherapeuticsInc's after-hype downside and upside margins for the prediction period are 0.20 and 8.13, respectively. We have considered Lyra TherapeuticsInc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lyra TherapeuticsInc is slightly risky at this time. Analysis and calculation of next after-hype price of Lyra TherapeuticsInc is based on 3 months time horizon.
Lyra TherapeuticsInc Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lyra TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lyra TherapeuticsInc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lyra TherapeuticsInc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 4.42 | 0.09 | 0.11 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.03 | 4.02 | 0.00 |
|
Lyra TherapeuticsInc Hype Timeline
Lyra TherapeuticsInc is now traded for 4.03. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of 0.11. Lyra is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.2%. %. The volatility of related hype on Lyra TherapeuticsInc is about 787.53%, with the expected price after the next announcement by competition of 4.14. About 82.0% of the company shares are owned by institutional investors. The book value of Lyra TherapeuticsInc was now reported as 1.27. The company has Price/Earnings To Growth (PEG) ratio of 1.61. Lyra TherapeuticsInc recorded a loss per share of 1.26. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Lyra TherapeuticsInc Basic Forecasting Models to cross-verify your projections.Lyra TherapeuticsInc Related Hype Analysis
Having access to credible news sources related to Lyra TherapeuticsInc's direct competition is more important than ever and may enhance your ability to predict Lyra TherapeuticsInc's future price movements. Getting to know how Lyra TherapeuticsInc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lyra TherapeuticsInc may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PXMD | PaxMedica Common Stock | (0.01) | 6 per month | 9.89 | 0.03 | 12.50 | (11.29) | 116.78 | |
| REVB | Revelation Biosciences | (0.26) | 8 per month | 0.00 | (0.1) | 12.76 | (12.02) | 74.56 | |
| VRAX | Virax Biolabs Group | (0.05) | 3 per month | 0.00 | (0.1) | 6.06 | (7.04) | 24.36 | |
| NRBO | Neurobo Pharmaceuticals | (0.57) | 8 per month | 5.40 | 0.05 | 9.65 | (10.81) | 81.23 | |
| ALLR | Allarity Therapeutics | 5.70 | 9 per month | 0.00 | (0.43) | 5.78 | (12.25) | 36.87 | |
| BDRX | Biodexa Pharmaceticals | 0.01 | 7 per month | 7.23 | 0.03 | 15.91 | (11.76) | 107.49 | |
| UNCY | Unicycive Therapeutics | (0.07) | 8 per month | 4.47 | 0.07 | 12.33 | (6.87) | 26.64 | |
| CDIO | Cardio Diagnostics Holdings | (0.26) | 8 per month | 0.00 | (0.18) | 10.76 | (13.79) | 48.38 |
Lyra TherapeuticsInc Additional Predictive Modules
Most predictive techniques to examine Lyra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lyra using various technical indicators. When you analyze Lyra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lyra TherapeuticsInc Predictive Indicators
The successful prediction of Lyra TherapeuticsInc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lyra TherapeuticsInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lyra TherapeuticsInc based on analysis of Lyra TherapeuticsInc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lyra TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lyra TherapeuticsInc's related companies. | 2023 | 2024 (projected) | Graham Number | 7.13 | 14.15 | Receivables Turnover | 6.7 | 5.96 |
Story Coverage note for Lyra TherapeuticsInc
The number of cover stories for Lyra TherapeuticsInc depends on current market conditions and Lyra TherapeuticsInc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lyra TherapeuticsInc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lyra TherapeuticsInc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Lyra TherapeuticsInc Short Properties
Lyra TherapeuticsInc's future price predictability will typically decrease when Lyra TherapeuticsInc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lyra TherapeuticsInc often depends not only on the future outlook of the potential Lyra TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lyra TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.8 M | |
| Cash And Short Term Investments | 102.8 M |
Check out Lyra TherapeuticsInc Basic Forecasting Models to cross-verify your projections. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Lyra Stock analysis
When running Lyra TherapeuticsInc's price analysis, check to measure Lyra TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra TherapeuticsInc is operating at the current time. Most of Lyra TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Lyra TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra TherapeuticsInc's price. Additionally, you may evaluate how the addition of Lyra TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Lyra TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra TherapeuticsInc. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.298 | Return On Assets (0.38) | Return On Equity (0.96) |
The market value of Lyra TherapeuticsInc is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Lyra TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra TherapeuticsInc's market value can be influenced by many factors that don't directly affect Lyra TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.